Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | calpain family protein 1, d | 0.0078 | 0.1182 | 0.1361 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0048 | 0.0251 | 0.0251 |
Onchocerca volvulus | Deterin homolog | 0.0093 | 0.1657 | 1 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0152 | 0.3476 | 0.3476 |
Brugia malayi | RNA binding protein | 0.032 | 0.8685 | 0.8685 |
Echinococcus granulosus | baculoviral IAP repeat containing protein | 0.0093 | 0.1657 | 0.1907 |
Leishmania major | calpain, putative,cysteine peptidase, Clan CA, family C2, putative | 0.004 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0106 | 0.205 | 0.205 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0104 | 0.1983 | 0.1983 |
Brugia malayi | TAR-binding protein | 0.032 | 0.8685 | 0.8685 |
Schistosoma mansoni | hypothetical protein | 0.0048 | 0.0251 | 0.0289 |
Echinococcus granulosus | inhibitor of apoptosis protein | 0.0093 | 0.1657 | 0.1907 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0362 | 1 | 1 |
Echinococcus multilocularis | tar DNA binding protein | 0.032 | 0.8685 | 1 |
Trypanosoma brucei | calpain-like protein, putative | 0.004 | 0 | 0.5 |
Schistosoma mansoni | family C2 unassigned peptidase (C02 family) | 0.0106 | 0.205 | 0.2361 |
Onchocerca volvulus | 0.0093 | 0.1657 | 1 | |
Echinococcus multilocularis | inhibitor of apoptosis protein | 0.0093 | 0.1657 | 0.1907 |
Echinococcus granulosus | tar DNA binding protein | 0.032 | 0.8685 | 1 |
Brugia malayi | calpain family protein 1 | 0.0106 | 0.205 | 0.205 |
Schistosoma mansoni | hypothetical protein | 0.0093 | 0.1657 | 0.1907 |
Schistosoma mansoni | hypothetical protein | 0.0048 | 0.0251 | 0.0289 |
Trypanosoma cruzi | calpain cysteine peptidase, putative | 0.004 | 0 | 0.5 |
Echinococcus granulosus | GPCR family 2 | 0.0048 | 0.0251 | 0.0289 |
Leishmania major | calpain-like cysteine peptidase, putative,cysteine peptidase, Clan CA, family C2, putative | 0.004 | 0 | 0.5 |
Brugia malayi | calpain family protein 1 | 0.0106 | 0.205 | 0.205 |
Trypanosoma cruzi | calpain-like cysteine peptidase, putative | 0.004 | 0 | 0.5 |
Brugia malayi | RNA recognition motif domain containing protein | 0.032 | 0.8685 | 0.8685 |
Trypanosoma cruzi | calpain-like cysteine peptidase, putative | 0.004 | 0 | 0.5 |
Echinococcus multilocularis | GPCR, family 2 | 0.0048 | 0.0251 | 0.0289 |
Schistosoma mansoni | hypothetical protein | 0.0104 | 0.1983 | 0.2283 |
Loa Loa (eye worm) | hypothetical protein | 0.0152 | 0.3476 | 0.3476 |
Trypanosoma brucei | antigen, putative | 0.004 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0104 | 0.1983 | 0.1983 |
Trypanosoma cruzi | calpain-like cysteine peptidase, putative | 0.004 | 0 | 0.5 |
Schistosoma mansoni | family C2 unassigned peptidase (C02 family) | 0.0111 | 0.22 | 0.2533 |
Plasmodium vivax | calpain, putative | 0.004 | 0 | 0.5 |
Echinococcus granulosus | family C2 unassigned peptidase C02 family | 0.0111 | 0.22 | 0.2533 |
Trypanosoma cruzi | cysteine peptidase, Clan CA, family C2, putative | 0.004 | 0 | 0.5 |
Echinococcus multilocularis | calpain A | 0.0111 | 0.22 | 0.2533 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0048 | 0.0251 | 0.0251 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0048 | 0.0251 | 0.0251 |
Schistosoma mansoni | tar DNA-binding protein | 0.032 | 0.8685 | 1 |
Leishmania major | calpain-like cysteine peptidase, putative,cysteine peptidase, Clan CA, family C2, putative | 0.004 | 0 | 0.5 |
Loa Loa (eye worm) | TAR-binding protein | 0.032 | 0.8685 | 0.8685 |
Loa Loa (eye worm) | hypothetical protein | 0.0093 | 0.1657 | 0.1657 |
Trypanosoma brucei | calpain-like cysteine peptidase, putative | 0.004 | 0 | 0.5 |
Loa Loa (eye worm) | calpain family protein 1 | 0.0078 | 0.1182 | 0.1182 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0048 | 0.0251 | 0.0289 |
Schistosoma mansoni | tar DNA-binding protein | 0.032 | 0.8685 | 1 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0152 | 0.3476 | 0.3476 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.032 | 0.8685 | 0.8685 |
Echinococcus granulosus | calpain A | 0.0111 | 0.22 | 0.2533 |
Echinococcus multilocularis | family C2 unassigned peptidase (C02 family) | 0.0111 | 0.22 | 0.2533 |
Trypanosoma brucei | calpain-like protein, putative | 0.004 | 0 | 0.5 |
Schistosoma mansoni | inhibitor of apoptosis (iap) domain family member | 0.0093 | 0.1657 | 0.1907 |
Loa Loa (eye worm) | hypothetical protein | 0.0078 | 0.1182 | 0.1182 |
Brugia malayi | Inhibitor of Apoptosis domain containing protein | 0.0093 | 0.1657 | 0.1657 |
Schistosoma mansoni | tar DNA-binding protein | 0.032 | 0.8685 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0093 | 0.1657 | 0.1657 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0152 | 0.3476 | 0.3476 |
Brugia malayi | Inhibitor of Apoptosis domain containing protein | 0.0093 | 0.1657 | 0.1657 |
Trypanosoma brucei | calpain-like protein, putative | 0.004 | 0 | 0.5 |
Loa Loa (eye worm) | calpain family protein 1 | 0.0106 | 0.205 | 0.205 |
Schistosoma mansoni | tar DNA-binding protein | 0.032 | 0.8685 | 1 |
Schistosoma mansoni | inhibitor of apoptosis protein | 0.0093 | 0.1657 | 0.1907 |
Loa Loa (eye worm) | hypothetical protein | 0.0094 | 0.1677 | 0.1677 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.0048 | 0.0251 | 0.0289 |
Schistosoma mansoni | hypothetical protein | 0.0048 | 0.0251 | 0.0289 |
Schistosoma mansoni | family C2 unassigned peptidase (C02 family) | 0.0111 | 0.22 | 0.2533 |
Loa Loa (eye worm) | hypothetical protein | 0.0048 | 0.0251 | 0.0251 |
Trypanosoma cruzi | calpain-like cysteine peptidase, putative | 0.004 | 0 | 0.5 |
Trypanosoma brucei | calpain-like protein, putative | 0.004 | 0 | 0.5 |
Echinococcus multilocularis | baculoviral IAP repeat containing protein | 0.0093 | 0.1657 | 0.1907 |
Schistosoma mansoni | hypothetical protein | 0.0048 | 0.0251 | 0.0289 |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.0048 | 0.0251 | 0.0289 |
Loa Loa (eye worm) | RNA binding protein | 0.032 | 0.8685 | 0.8685 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0362 | 1 | 1 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0048 | 0.0251 | 0.0289 |
Trypanosoma cruzi | calpain-like cysteine peptidase, putative | 0.004 | 0 | 0.5 |
Trypanosoma cruzi | cysteine peptidase, Clan CA, family C2, putative | 0.004 | 0 | 0.5 |
Trypanosoma cruzi | cysteine peptidase, Clan CA, family C2, putative | 0.004 | 0 | 0.5 |
Trypanosoma brucei | cysteine peptidase, Clan CA, family C2, putative | 0.004 | 0 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.032 | 0.8685 | 1 |
Trypanosoma cruzi | cysteine peptidase, Clan CA, family C2, putative | 0.004 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0066 | 0.0808 | 0.0808 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Inhibition (binding) | = 88 % | The compound was evaluated for irreversible inhibition of HIV-1 protease at 20 microM | ChEMBL. | No reference |
Inhibition (binding) | = 88 % | The compound was evaluated for irreversible inhibition of HIV-1 protease at 20 microM | ChEMBL. | No reference |
K inact (binding) | = 1.8 mM | The compound was evaluated for irreversible inhibition of HIV-1 protease at pH 6.5 | ChEMBL. | No reference |
K inact (binding) | = 1.8 mM | The compound was evaluated for irreversible inhibition of HIV-1 protease at pH 6.5 | ChEMBL. | No reference |
Ratio (binding) | = 140000 M-1 min-1 | Bimolecular rate constant is the ratio of Vinact/Kinact | ChEMBL. | No reference |
Vinact (binding) | = 0.26 min-1 | Maximal inactivation rate of the compound towards HIV-1 protease was evaluated | ChEMBL. | No reference |
Vinact (binding) | = 0.26 min-1 | Maximal inactivation rate of the compound towards HIV-1 protease was evaluated | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.